This report is one in a series of reports that provide a snapshot of substance abuse treatment in various metropolitan areas nationwide. This report focuses on substance abuse treatment admissions and treatment facilities in the Metropolitan Statistical Area (MSA)1 of Manchester-Nashua, New Hampshire,2 hereafter referred to as Manchester.
Data presented in this report are derived from the Treatment Episode Data Set (TEDS),3 which collects information on the characteristics of persons admitted to substance abuse treatment, and the National Survey of Substance Abuse Treatment Services (N-SSATS),4 an annual survey of treatment facilities. Both TEDS and N-SSATS are conducted by the Office of Applied Studies, Substance Abuse and Mental Health Services Administration (SAMHSA).
Demographic Characteristics of Treatment Admissions
In 2008, there were approximately 2,000 total substance abuse treatment admissions in Manchester: 64 percent were male and 36 percent were female.
The age and race/ethnicity of treatment admissions in Manchester are shown below in Figures 1 and 2.
Figure 1. Treatment Admissions by Age: Manchester: TEDS 2008
Source: Treatment Episode Data Set (TEDS) 2008
Figure 1 Table. Treatment Admissions by Age: Manchester: TEDS 2008
Age
Treatment Admissions
Under 18
10%
18 to 24
23%
25 to 34
27%
35 to 44
23%
45 or Older
17%
Source: Treatment Episode Data Set (TEDS) 2008
Figure 2. Treatment Admissions by Race/Ethnicity: Manchester: TEDS 2008
Source: Treatment Episode Data Set (TEDS) 2008
Figure 2 Table. Treatment Admissions by Race/Ethnicity: Manchester: TEDS 2008
Race/Ethnicity
Treatment Admissions
Non-Hispanic White
72%
Hispanic
25%
All Other
3%
Source: Treatment Episode Data Set (TEDS) 2008
Primary Substance of Abuse5 Reported at Treatment Admission
Compared with the Nation as a whole and the State of New Hampshire, treatment admissions in Manchester were:
more likely than all U.S. admissions and less likely than admissions in New Hampshire as a whole to report alcohol, and
less likely than U.S. admissions, and about equally likely as New Hampshire admissions as a whole to report marijuana (Figure 3).
Figure 3. Treatment Admissions: Primary Substance of Abuse: United States, New Hampshire, and Manchester: TEDS 2008
Source: Treatment Episode Data Set (TEDS) 2008
Figure 3 Table. Treatment Admissions: Primary Substance of Abuse: United States, New Hampshire, and Manchester: TEDS 2008
Primary Substance
of Abuse
Location
Treatment
Admissions
Alcohol
United States
41%
Alcohol
New Hampshire
51%
Alcohol
Manchester
45%
Marijuana
United States
17%
Marijuana
New Hampshire
13%
Marijuana
Manchester
14%
Heroin
United States
14%
Heroin
New Hampshire
13%
Heroin
Manchester
15%
Prescription Painkillers
United States
6%
Prescription Painkillers
New Hampshire
10%
Prescription Painkillers
Manchester
9%
Smoked Cocaine
United States
8%
Smoked Cocaine
New Hampshire
5%
Smoked Cocaine
Manchester
8%
Source: Treatment Episode Data Set (TEDS) 2008
By Gender
Males and females reported alcohol as their primary substance of abuse more often than other substances.
Second to alcohol, females most frequently reported heroin, followed by smoked cocaine and marijuana, and males most frequently reported marijuana and heroin.
Compared with males, females were more likely to report prescription painkillers and smoked cocaine and less likely to report alcohol or marijuana (Figure 4).
Figure 4. Treatment Admissions: Primary Substance of Abuse by Gender: Manchester: TEDS 2008
Source: Treatment Episode Data Set (TEDS) 2008
Figure 4 Table. Treatment Admissions: Primary Substance of Abuse by Gender: Manchester: TEDS 2008
Primary Substance
of Abuse
Gender
Treatment
Admissions
Alcohol
Males
47%
Alcohol
Females
40%
Marijuana
Males
16%
Marijuana
Females
11%
Heroin
Males
15%
Heroin
Females
16%
Prescription Painkillers
Males
8%
Prescription Painkillers
Females
10%
Smoked Cocaine
Males
6%
Smoked Cocaine
Females
11%
Source: Treatment Episode Data Set (TEDS) 2008
By Age
Admissions under the age of 18 reported marijuana as their primary substance of abuse more often than other substances. Reports of marijuana decreased with age.
Conversely, reports of alcohol increased with age. Alcohol was the most prevalent primary substance of abuse among admissions aged 25 and older.
Admissions aged 18 to 24 reported heroin as often as alcohol; those aged 25 to 34 also commonly reported heroin as a primary substance of abuse (Figure 5).
Figure 5. Treatment Admissions: Primary Substance of Abuse by Age: Manchester: TEDS 2008
Source: Treatment Episode Data Set (TEDS) 2008
Figure 5 Table. Treatment Admissions: Primary Substance of Abuse by Age: Manchester: TEDS 2008
Age
Primary Substance
of Abuse
Treatment
Admissions
Under 18
Alcohol
24%
Under 18
Marijuana
66%
Under 18
Heroin
1%
Under 18
Prescription Painkillers
4%
Under 18
Smoked Cocaine
1%
18 to 24
Alcohol
26%
18 to 24
Marijuana
20%
18 to 24
Heroin
26%
18 to 24
Prescription Painkillers
14%
18 to 24
Smoked Cocaine
5%
25 to 34
Alcohol
37%
25 to 34
Marijuana
6%
25 to 34
Heroin
24%
25 to 34
Prescription Painkillers
10%
25 to 34
Smoked Cocaine
9%
35 to 44
Alcohol
56%
35 to 44
Marijuana
5%
35 to 44
Heroin
9%
35 to 44
Prescription Painkillers
6%
35 to 44
Smoked Cocaine
15%
45 or Older
Alcohol
77%
45 or Older
Marijuana
2%
45 or Older
Heroin
3%
45 or Older
Prescription Painkillers
4%
45 or Older
Smoked Cocaine
6%
Source: Treatment Episode Data Set (TEDS) 2008
By Race/Ethnicity
Non-Hispanic White and Hispanic admissions reported alcohol as their primary substance of abuse more often than other substances.
Compared with Hispanic admissions, non-Hispanic Whites were more likely to report heroin and less likely to report marijuana (Figure 6).
Figure 6. Treatment Admissions: Primary Substance of Abuse by Race/Ethnicity: Manchester: TEDS 2008
Source: Treatment Episode Data Set (TEDS) 2008
Figure 6 Table. Treatment Admissions: Primary Substance of Abuse by Race/Ethnicity: Manchester: TEDS 2008
Race/Ethnicity
Primary Substance
of Abuse
Treatment
Admissions
Non-Hispanic
Alcohol
44%
Non-Hispanic
Marijuana
13%
Non-Hispanic
Heroin
17%
Non-Hispanic
Prescription Painkillers
9%
Non-Hispanic
Smoked Cocaine
8%
Hispanic
Alcohol
44%
Hispanic
Marijuana
16%
Hispanic
Heroin
12%
Hispanic
Prescription Painkillers
7%
Hispanic
Smoked Cocaine
9%
Source: Treatment Episode Data Set (TEDS) 2008
Injection Drug Use
Of the total admissions in Manchester, 19 percent reported injection drug use.
Sources of Referral
Individual/self-referrals and the criminal justice system were the primary sources of referral to treatment in Manchester (41 percent each), followed by substance abuse providers (9 percent), and health care providers (5 percent) (Figure 7).
Figure 7. Source of Referrals to Treatment: Manchester: TEDS 2008
Source: Treatment Episode Data Set (TEDS) 2008
Figure 7 Table. Source of Referrals to Treatment: Manchester: TEDS 2008
Source of Referrals
Treatment Admissions
Criminal Justice
41%
Individual/Self
41%
Substance Abuse Providers
9%
Health Care Providers
5%
Other
4%
Source: Treatment Episode Data Set (TEDS) 2008
Substance Abuse Treatment Facilities
Types of Care
In 2008, 16 facilities in Manchester offered substance abuse treatment services: 14 facilities offered outpatient care, 6 facilities offered non-hospital residential care, and 1 facility offered hospital inpatient care. (Some facilities offered more than one type of care.)
Outpatient Care
Of the 14 facilities that offered outpatient substance abuse care, 50 percent provided intensive outpatient services, and 14 percent offered day treatment/partial hospitalization.
Regular outpatient treatment services were offered by 85 percent of outpatient facilities.
Residential Care
Of the 6 residential facilities in Manchester, 4 offered long-term residential treatment (more than 30 days), and 4 offered short-term residential treatment (30 days or less).
Detoxification Programs
A total of 10 facilities offered detoxification services. Of these facilities, 100 percent provided detoxification from opiates (heroin and prescription painkillers), 60 percent from alcohol, and 60 percent from cocaine.
Opioid Treatment Programs
Opioid treatment programs (OTPs) provide medication-assisted therapy with methadone and/or buprenorphine for the treatment of addiction to opiates such as heroin and prescription painkillers.
In 2008, 4 of the 16 treatment facilities (25 percent) in Manchester operated OTPs. On a typical day,6 827 clients at these OTPs were receiving medication-assisted opioid therapy with methadone or buprenorphine.7
1 MSAs are geographic entities used by Federal statistical agencies to collect, analyze, and publish Federal statistics and are defined by the U.S. Office of Management and Budget. 2 The Manchester-Nashua, New Hampshire MSA includes Hillsborough County. 3 The Treatment Episode Data Set (TEDS) is a compilation of data on the demographic and substance abuse problems of those admitted for substance abuse treatment. The information comes primarily from facilities that receive some public funding. Information on treatment admissions is routinely collected by State administrative systems and submitted to the Substance Abuse and Mental Health Services Administration (SAMHSA) in a standard format. TEDS records represent admissions rather than individuals, because a person may be admitted to treatment more than once. See the annual TEDS reports at http://www.oas.samhsa.gov/dasis.htm#teds3. 4 The National Survey of Substance Abuse Treatment Services (N-SSATS) is designed to collect information from all facilities in the United States, both public and private, that provide substance abuse treatment. N-SSATS does not collect information from the following three types of facilities: non-treatment halfway houses; jails, prisons, or other organizations that treat incarcerated clients exclusively; and solo practitioners. 5 TEDS collects information on up to three substances of abuse that lead to the treatment episode. The main substance abused by the client is known as the "primary substance of abuse." 6 N-SSATS collected information on the number of clients in treatment at each facility on the survey reference date of March 31, 2008. 7 It is possible that the number of clients receiving treatment at opioid treatment programs (OTPs) on the N-SSATS reference date will appear relatively large in comparison with the number of annual treatment admissions based on data from TEDS. Reasons for this include: (1) persons receiving medication-assisted opioid therapy often remain in treatment for extended periods of time and thus do not show up in an annual count of admissions to treatment; and (2) some private for-profit OTPs do not report to TEDS but are surveyed in the N-SSATS.
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration www.samhsa.gov
This page was last updated on
January 07, 2010.
SAMHSA,
an agency in the Department of Health and Human Services, is the Federal
Government's lead agency for improving the quality and availability of
substance abuse prevention, addiction treatment, and mental health
services in the United States.
